Filing Details
- Accession Number:
- 0001127602-18-000931
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-04 11:12:41
- Reporting Period:
- 2018-01-02
- Accepted Time:
- 2018-01-04 11:12:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100682 | Charles River Laboratories International Inc | CRL | Services-Commercial Physical & Biological Research (8731) | 061397316 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1141722 | C James Foster | 251 Ballardvale Street Wilmington MA 01887 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-01-02 | 200 | $109.64 | 315,099 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 10 | $109.65 | 315,089 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 400 | $109.66 | 314,689 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 100 | $109.68 | 314,589 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 200 | $109.68 | 314,389 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 100 | $109.69 | 314,289 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 100 | $109.69 | 314,189 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 200 | $109.70 | 313,989 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 700 | $109.72 | 313,289 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 900 | $109.73 | 312,389 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 400 | $109.74 | 311,989 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 600 | $109.75 | 311,389 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 300 | $109.76 | 311,089 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 383 | $109.76 | 310,706 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 200 | $109.77 | 310,506 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 400 | $109.79 | 310,106 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 290 | $109.80 | 309,816 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 100 | $109.81 | 309,716 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 84 | $109.82 | 309,632 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 300 | $109.83 | 309,332 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 212 | $109.86 | 309,120 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 43 | $109.90 | 309,077 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 300 | $109.95 | 308,777 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 300 | $110.01 | 308,477 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 300 | $110.02 | 308,177 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-01-02 | 200 | $110.03 | 307,977 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This sale occurred pursuant to a 10b5-1 Trading Plan.